Risetherapeutics

1 known investors

Rise Therapeutics develops precision immunotherapy drugs, specifically oral immune biomodulators designed through synthetic biology for the treatment of autoimmune diseases and cancer. The company integrates advanced oral drug delivery with clinical manufacturing and regulatory expertise to advance first-in-class immunotherapies through clinical trials.

BiotechDeep TechDigital Health